A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy

Clinical trial NCT01728298 · COMPLETED

Trial details

NCT number: NCT01728298
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2012-11-01
Primary completion: 2013-08-01
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.